Compounds > tariquidar
Page last updated: 2024-09-04

tariquidar and pheophorbide a

tariquidar has been researched along with pheophorbide a in 3 studies

Compound Research Comparison

Studies
(tariquidar)		Trials
(tariquidar)		Recent Studies (post-2010)
(tariquidar)		Studies
(pheophorbide a)		Trials
(pheophorbide a)		Recent Studies (post-2010) (pheophorbide a)
210161382780145

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gallus, J; Krapf, MK; Vahdati, S; Wiese, M1
Bates, SE; Blayney, M; Mistry, P; Morisaki, K; Polgar, O; Robey, RW; Steadman, K1
Klinkhammer, W; Pick, A; Wiese, M1

Other Studies

3 other study(ies) available for tariquidar and pheophorbide a

ArticleYear
New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold.
    Journal of medicinal chemistry, 2018, 04-26, Volume: 61, Issue:8

    Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mice; Molecular Structure; Neoplasm Proteins; Pyridines; Pyrimidines; Structure-Activity Relationship

2018
Pheophorbide a is a specific probe for ABCG2 function and inhibition.
    Cancer research, 2004, Feb-15, Volume: 64, Issue:4

    Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Camptothecin; Chlorophyll; Drug Resistance, Neoplasm; Humans; Irinotecan; Neoplasm Proteins; Quinolines; Staurosporine; Topotecan

2004
Specific inhibitors of the breast cancer resistance protein (BCRP).
    ChemMedChem, 2010, Sep-03, Volume: 5, Issue:9

    Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Chlorophyll; Diketopiperazines; Drug Resistance, Multiple; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Imatinib Mesylate; Indoles; Neoplasm Proteins; Novobiocin; Piperazines; Pyrimidines; Quinolines; Structure-Activity Relationship

2010